Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese

Title
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
Authors
Keywords
Diabetes mellitus, Non-melanoma skin cancer, Rosiglitazone, Taiwan
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-05
DOI
10.1186/s12885-015-1057-8

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started